|

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

RECRUITINGN/ASponsored by University Hospital, Brest
Actively Recruiting
PhaseN/A
SponsorUniversity Hospital, Brest
Started2025-05-15
Est. completion2026-03
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goal of this clinical trial is to demonstrate that simulation training for paramedical staff in neurosurgery departments, in announcing and accompanying patients with a brain tumor, improves patient satisfaction when a (potentially malignant) brain tumor is discovered, compared with usual care. The main question it aims to answer is: \- Are patients more satisfied (as measured by scores on the EORCT IN-PATSAT32 questionnaire) with their neurosurgical hospitalization following the discovery of a brain tumor in centers where paramedics have been trained by simulation? Researchers will compare the results of the EORTC IN-PATSAT32 questionnaire to determine whether paramedic training improves patient satisfaction between simulation-trained and untrained centers. Participants will be asked to complete the EORT IN-PATSAT32 questionnaire at the end of their hospital stay.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient over 18 years of age
* Patient covered by a social security scheme
* Patient signed informed consent form
* Patient found to have a brain tumor (potentially malignant, primary or secondary if this is the mode of entry into the disease)
* Hospitalization in the Neurosurgery Department at the time of tumor discovery, before the histological diagnosis is announced.

Exclusion Criteria:

* Patients with a personal history of cancer
* Patient without family AND unable to receive information

Conditions2

Brain Tumor AdultCancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.